Evidence map›Paper›PMID 34943076›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors.

Armanda Teixeira-Gomes, Blanca Laffon, Vanessa Valdiglesias, Johanna M Gostner, Thomas Felder, Carla Costa, Joana Madureira, Dietmar Fuchs, João Paulo Teixeira, Solange Costa

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Armanda Teixeira-GomesEPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Blanca LaffonCentro de Investigaciones Científicas Avanzadas (CICA), Grupo DICOMOSA, Departamento de Psicología, Facultad de Ciencias de la Educación, Campus Elviña s/n, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-7649-2599
Vanessa ValdiglesiasInstituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC. Oza, 15071 A Coruña, Spain.ORCID 0000-0002-5572-1089
Johanna M GostnerInstitute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-1532-5177
Thomas FelderDepartment of Laboratory Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-8266-5513
Carla CostaEPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Joana MadureiraEPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Dietmar FuchsInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-1627-9563
João Paulo TeixeiraEPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.ORCID 0000-0001-8693-5250
Solange CostaEPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.
Universidade do Porto · PTInnsbruck Medical University · ATUniversidade da Coruña · ESParacelsus Medical University · AT

Funding

Fundação para a Ciência e Tecnologia SFRH/BD/121802/2016Fundação para a Ciência e Tecnologia SFRH/BPD/100948/2014Fundação para a Ciência e Tecnologia SFRH/BPD/115112/2016Ministerio de Ciencia e Innovación PID2020-113788RB-I00Ministerio de Educación Cultura y Deporte BEAGAL18/00142
6 · The paper itself

Abstract

Ageing is accompanied with a decline in several physiological systems. Frailty is an age-related syndrome correlated to the loss of homeostasis and increased vulnerability to stressors, which is associated with increase in the risk of disability, comorbidity, hospitalisation, and death in older adults. The aim of this study was to understand the relationship between frailty syndrome, immune activation, and oxidative stress. Serum concentrations of vitamins A and E were also evaluated, as well as inflammatory biomarkers (CRP and IL-6) and oxidative DNA levels. A group of Portuguese older adults (≥65 years old) was engaged in this study and classified according to Fried's frailty phenotype. Significant increases in the inflammatory mediators (CRP and IL-6), neopterin levels, kynurenine to tryptophan ratio (Kyn/Trp), and phenylalanine to tyrosine ratio (Phe/Tyr), and significant decreases in Trp and Tyr concentrations were observed in the presence of frailty. IL-6, neopterin, and Kyn/Trp showed potential as predictable biomarkers of frailty syndrome. Several clinical parameters such as nutrition, dependency scales, and polypharmacy were related to frailty and, consequently, may influence the associations observed. Results obtained show a progressive immune activation and production of pro-inflammatory molecules in the presence of frailty, agreeing with the inflammageing model. Future research should include different dimensions of frailty, including psychological, social, biological, and environmental factors.

Indexed as

CRP and IL-6frailtyKyn/Trpmodifiable risk factorsneopterinnitriteoxidative DNA damageoxi-immune markersPhe/Tyrvitamin A and vitamin E

Identifiers

PMID34943076
PMCPMC8750623
OpenAlexW4200417246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.